CT-04

N/A

Report date: 2025/01/26 18:14:45
NME

Base Information

Drug NameCT-04
Drug Alias NameE3 ligase-based bifunctional degraders (Captor Therapeutics)CT-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases modulatorsWingless type MMTV integration site family protein inhibitors
TargetsUbiquitin-protein ligasesWingless type MMTV integration site family protein
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaptor Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesCaptor Therapeutics SA
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A